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Microbacterium species (formerly CDC [Centers for Disease Control and Prevention] coryneform
group A-4 and A-5 bacteria) are widely distributed in the environment and rarely cause infections
in humans. We present a case of endophthalmitis due to Microbacterium species that occurred after
accidental trauma and review the literature on microbacterium infections. If the infected tissue or
medical device is removed and antimicrobial therapy (preferably with fl-lactarns or glycopeptides)
is instituted, the prognosis is usually favorable for patients with microbacterium infections.
Infections due to coryneform bacteria have been reported
with increasing frequency within the last few years. The reasons
for this increase may be the use of intensified and more-inva-
sive therapy regimens, an increase in the number of immuno-
compromised patients, and an increased awareness regarding
the pathogenic potential of coryneform bacteria. In addition,
tremendous efforts have been made to clarify the taxonomy of
coryneform bacteria, and thus many new genera and species
have been described [1].
Strains belonging to the genus Microbacterium have recently
been recognized as pathogens in humans; these strains were
previously designated CDC (Centers for Disease Control and
Prevention) coryneform groups A-4 and A-5 bacteria [2]. At
present, it is almost impossible to identify individual species
within the genus Microbacterium because the majority of de-
scriptions of the six presently defined species that constitute
the genus are based on only very few strains. Microbacterium
strains are widely distributed in the environment (e.g., they are
found in the soil and in sewage) [2, 3].
We report a case of endophthalmitis caused by a Microbacte-
rium species after accidental trauma. A review of the literature
revealed five other cases in which Microbacterium species
caused severe infections.
Case Report
A 34-year-old male sustained an intraocular foreign-body
injury while working with a steel hammer in an opencast mine.
On admission, physical examination revealed conjunctival in-
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jection of the right eye, perforation of the cornea, a deep ante-
rior chamber with 2+ cells, and a perforated lens with cataracts.
Blood was seen in the vitreous. A roentgenogram of the right
orbit showed a single intraocular foreign body (2 X 1.5 mm)
with a metallic density. Subsequent ophthalmologic treatment
included closing the corneal laceration; incision of the sclera,
with magnetic extraction of the foreign body via pars plana;
and lensectomy. Extraction of the foreign body via pars Plana;
and lensectomy.
Empirical antibiotic therapy with iv cefazolin (2 g t.i.d.) was
started, but the drug was not applied intravitreously. Four days
after this initial treatment, the patient presented with severe
pain and clouding of the anterior vitreous. An anterior vitrec-
tomy was performed to establish the diagnosis of endophthal-
mitis. During surgery, 0.4 mg of tobramycin were injected
into the vitreous cavity, and 40 mg of gentamicin were given
subconjunctivally. The patient started receiving iv therapy with
gentamicin (80 mg b.i.d.), cefotiam (2 g b.i.d.), and clinda-
mycin (300 mg t.i.d.).
The vitreous and the aspirate from the anterior chamber were
both purulent (there were 5 leukocytes per high-power field),
but no microorganisms were seen on direct gram stains (as
reviewed by one of the authors). Within 24 hours, cultures of
specimens of the aspirate and vitreous on sheep blood agar
plates as well as on chocolate agar plates yielded light, pure
growth of yellow-pigmented colonies (1 mm in diameter), but
no growth was observed on MacConkey agar plates.
Microscopic examination revealed small gram-positive rods.
They were immotile and did not reduce nitrate; they hydrolyzed
esculin but not urea; they fermented glucose, maltose, sucrose,
mannitol, and xylose, resulting in the production of acid but no
gas (former CDC coryneform group A-4 bacteria). Additional
chemotaxonomic investigations revealed that lysine was the
diamino acid of the cell wall peptidoglycan and that the domi-
nant cellular fatty acids were ai-C15:0 (31%) and ai-C17:0
(39%). On the basis of these findings, the isolate was assigned
to the genus Microbacterium [2, 3]. Fungal cultures of the
aspirate and vitreous remained negative.
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Antimicrobial susceptibility testing was performed on
Mueller-Hinton agar plates with use of the Etest or broth
microdilution [4]. The following MICs were obtained for the
isolate: cefazolin, <0.25 ktg/mL; cefotiam, <0.25 pg/mL; ci-
profloxacin, 0.19 p,g/mL; clindamycin, 0.19 ,ug/mL; gentami-
cin, >64 ug/mL; imipenem, 0.25 p,g/mL; piperacillin, 0.032
,ag/mL; tobramycin, >64 tg/mL; teicoplanin, 0.25 ,ug/mL; and
vancomycin, 0.25 pg/mL. It remained unclear why the patient's
condition deteriorated while he was receiving cefazolin.
To determine the exact phylogenetic position of the patient's
isolate, we sequenced almost the entire 16S rRNA gene (Euro-
pean Molecular Biology Laboratory accession no. X95482)
according to the method of Hiraishi [5]. Phylogenetic analysis
was performed on the basis of 1,253 alignable nucleotides
by using the neighbor-joining method and including bootstrap
analysis with 100 resampled data sets that were compared with
published sequences of the type strains of the genus Microbac-
terium [6] and phylogenetically related bacteria [7]. Methods
and programs used for this analysis have previously been de-
scribed in detail [8].
In the resulting phylogenetic tree (figure 1), our patient's
isolate (GH 942) clustered together with Microbacterium lae-
vaniformans and Microbacterium dextranolyticum, a finding
that confirmed its place in the genus Microbacterium. Quantita-
tive DNA-DNA hybridizations may reveal whether the pa-
tient's isolate represents a new species of the genus Microbac-
terium.
After surgery the patient's anterior chamber gradually
cleared, and the vitreous inflammation decreased. He was dis-
charged on the 21st day after the injury. At this time, he was
able to see hand movements; no hypopyon was observed, and
the vitreous was slightly hazy. Two months after the injury,
ophthalmologic examination revealed that the eye was clear
with no signs of infection or retinal detachment. Slight edema
of the macula was noted. Three months after the accident, the
best corrected visual acuity was 15/36.
0.1 substitutions/site
Agromyces mediolanus
95% anLAgromyces cerinus
Agromyces ramosum
96 % Microbacterium laevaniformans
100% 	 Microbacterium dextranolyticum
GH 942
	Microbacterium aurum
- Microbacterium lacticum
- Aureobacterium species (strain Mainz)
- Aureobacterium liquefaciens
Aureobacterium testaceum
	 Aureobacterium barkeri
90% 100%[ Microbacterium arborescensMicrobacterium imperiale
100% Clavibacter xyli
"Corynebacterium aquaticum"
100% Curtobacterium citreum
Curtobacterium luteum
	 "Brevibacterium helvolum"
	 Clavibacter michiganensis
98% 	 Rathayibacter tritici
Rathayibacter rathayi
Brevibacterium linens
Figure 1. Phylogenetic position of an isolate (strain GH 942) from
a patient with microbacterium endophthalmitis, as inferred by analysis
of 16S rDNA in other actinomycetes with group B-peptidoglycan. The
neighbor-joining method was used. Numbers within the tree represent
bootstrap values. Statistically non-supported nodes (<90%) were not
resolved.
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Review and Discussion
In all of the reported cases of microbacterium infections, the
patients were male (table 1). Three of the six patients had
endophthalmitis (two of these cases occurred after accidental
trauma, and one occurred after hematogenous spread of the
organism). Gram-positive rods were seen in a direct gram stain
in only one of these three cases. All three of these patients
with endophthalmitis underwent at least partial vitrectomy, and
all were found to have impaired vision after completing ther-
apy, which also included treatment with antimicrobial agents
(table 1).
Two of the six patients with microbacterium infections had
infected catheters, and both were immunocompromised as a
result of hematologic neoplasias. Because bacteremia persisted
in these two patients, the catheters had to be removed to achieve
cure. All six patients with microbacterium infections were
cured by removal of the infected tissue or medical device and
institution of antimicrobial therapy, and no other systemic man-
ifestations of microbacterium infection were observed.
The limited experience with microbacterium infections does
not allow a definitive recommendation for treatment at the
present time. However, it has been our experience (as in the
present report) that some Microbacterium strains have shown
resistance in vitro to aminoglycosides when MIC values were
interpreted according to the guidelines of the National Commit-
tee for Clinical Laboratory Standards [2].
Other investigators have also reported in vitro resistance to
aminoglycosides in their Microbacterium isolates [11, 12]. Re-
testing of the Microbacterium strain described by Campbell et
al. [12] revealed susceptibility to vancomycin (MIC, 2 //g/mL)
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Table 1. Summary of data from six cases of microbacterium infection.
Penetrating metallic 	 Endophthalmitis
foreign body
Initially, sj Gm; iv Gm,
Meth; anterior vitrectomy;
it Gm, Meth,
corticosteroids; iv Gm,
Meth, corticosteroids*
Vitrectomy; topical Ctax, Gm
for 3 w; po 5-FC, Ket for
4w
iv Amp for 6w
iv Tic/CA, Tm, Vm for 3 d;
iv Ctax for 3 d; removal of
infected CVC
iv Tic/CA, Gm, Cpfx for 2 d;
iv Tic/CA, Vm;* iv Ctri
for 4 d; removal of
infected Hickman catheter;
iv Ctri for 2 w
Initially, iv Cfaz for 3 d;
anterior vitrectomy; it Tm
+ sj Gm; iv Gm, Cti, Cm
for 3 w
1990 	 77/M 	 Abdominal surgery
1991 	 67/M 	 None
1994 	 11/M 	 Acute
myelomonocytic
leukemia
1995	 64/M 	 Myelodysplastic
syndrome
Hematogenous
endophthalmitist
Mitral valve
endocarditis
Septicemia
Sepsis
Case no.
[reference]
1 [9] 
Year 	 Age (y)/sex
1979 	 38/M 
Underlying 	 Microbacterium
condition 	 infection 	 Treatment (route, duration) Outcome
Impaired vision
(12/37 visus)
Impaired vision
(6/36 visus)
Cured
Survived
Survived
6 [PR] 	 1996 	 34/M 	 Penetrating metallic
	 Endophthalmitis
foreign body
Impaired vision
(15/36 visus)
NOTE. Amp = ampicillin; Cfaz = cefazolin; Cm = clindamycin; Cpfx = ciprofloxacin; Ctax = cefotaxime; Cti = cefotiam; Ctri = ceftriaxone; CVC =
central venous catheter; Gm = gentamicin; it = intravitreously; Ket = ketoconazole; Meth = methicillin; PR = present report; sj = subconjunctivally; Tic/CA
= ticarcillin/clavulanic acid; Tm = tobramycin; Vm = vancomycin; 5-FC = 5-fluorocytosine.
* Duration not given.
t Candida albicans was also isolated.
The biochemical reactions of the bacterial isolate recovered in this case did not clearly allow differentiation between Cellulomonas species and Microbacterium
species [14].
(author's unpublished data). Nearly all Microbacterium strains
described in the literature or tested by us were susceptible in vitro
to ,8-lactams [2, 10, 11, 13], drugs that should always be consid-
ered for the treatment of microbacterium infections.
All Microbacterium strains that have been reported were
susceptible to glycopeptides; thus these drugs may be used for
initial empirical therapy, until the results of susceptibility test-
ing are known, when coryneform bacteria are recovered from
specimens such as blood or the vitreous.
There is no doubt that microbacterium infections are rare in
humans. Three reference laboratories in Europe have received
or isolated only 13 Microbacterium strains over nearly two
decades [2]. However, it is likely that only severe infections
caused by Microbacterium species have been reported in the
literature. A series of papers described two atypical CDC cory-
neform group A-4 strains as causes of endophthalmitis after
intraocular lens implantation and corticosteroid therapy in two
female patients [15-17]. It was unclear why these strains were
still referred to as CDC coryneform group A-4 [16, 17], since
it was previously demonstrated that these two atypical CDC
coryneform group A-4 strains were in fact CDC coryneform
group 1 bacteria [18], which are now defined as Actinomyces
neuii [19].
The pathogenic potential of Microbacterium species has
been demonstrated in a rabbit endophthalmitis model; these
bacteria fulfill the Koch postulates for an etiologic agent of an
infectious process [9].
In accordance with the habitat of Microbacterium species,
the two strains involved in cases 1 and 6 (table 1) were acquired
from the environment. Microbacterium strains have also been
isolated from the hospital environment [2], but possible nosoco-
mial transmission of Microbacterium strains in cases 2, 4, and
5 (table 1) can only be suspected.
Finally, we emphasize that microbacterium infections are
rare but that they have been more frequently reported within
the last few years (table 1).
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